Sort   by:  
 Page size 
UnknownNivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival.
Not available
S-EPMC10025222 | biostudies-literature
UnknownReal-World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma.
Not available
S-EPMC9939122 | biostudies-literature
UnknownJoint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors.
Not available
S-EPMC8982432 | biostudies-literature
UnknownClinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data.
Not available
S-EPMC11076438 | biostudies-literature
Sort   by:  
 Page size